Quince Therapeutics, Inc. QNCX
QNCX
Quince Therapeutics, Inc. ATYR
aTyr Pharma, Inc. DTIL
Precision BioSciences, Inc. IFRX
InflaRx N.V. MGX
Metagenomi, Inc. Common Stock GUTS
Fractyl Health, Inc. Common Stock ALXO
ALX Oncology Holdings Inc. CNTB
Connect Biopharma Holdings Limited ADVM
Adverum Biotechnologies, Inc. CAMP
CAMP4 Therapeutics Corporation
Quince Therapeutics, Inc. ATYR
aTyr Pharma, Inc. DTIL
Precision BioSciences, Inc. IFRX
InflaRx N.V. MGX
Metagenomi, Inc. Common Stock GUTS
Fractyl Health, Inc. Common Stock ALXO
ALX Oncology Holdings Inc. CNTB
Connect Biopharma Holdings Limited ADVM
Adverum Biotechnologies, Inc. CAMP
CAMP4 Therapeutics Corporation
Performance
| Periode | QNCX | ATYR | DTIL | IFRX | MGX | GUTS | ALXO | CNTB | ADVM | CAMP |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 164.69 % | -85.93 % | -1.94 % | 27.55 % | 12.59 % | 8.50 % | 174.20 % | 147.37 % | 77.24 % | 329.55 % |
| YTD | 101.33 % | -81.29 % | 2.45 % | -60.00 % | -57.52 % | 4.93 % | -9.94 % | 94.21 % | -9.17 % | 34.18 % |
| 1Y | 98.17 % | -75.86 % | 1.37 % | -56.71 % | -48.23 % | 5.92 % | -8.77 % | 115.60 % | -17.11 % | 4.01 % |
| 3Y | 452.72 % | -57.72 % | -86.65 % | -55.16 % | -84.38 % | -82.61 % | -86.70 % | 170.11 % | -30.90 % | -38.29 % |
| 5Y | -87.98 % | -57.72 % | -98.00 % | -79.30 % | -84.38 % | -82.61 % | -98.27 % | -87.29 % | -96.75 % | -38.29 % |
| 10Y | -88.49 % | -57.72 % | -99.08 % | -93.33 % | -84.38 % | -82.61 % | -95.32 % | -87.29 % | -95.07 % | -38.29 % |
| From the beginning | -88.49 % | -57.72 % | -99.08 % | -93.33 % | -84.38 % | -82.61 % | -95.32 % | -87.29 % | -98.44 % | -38.29 % |